BDBM512307 Preparation of N-(3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-4-yl)oxy)-4-fluorophenyl)acrylamide::US11084823, Example 8

SMILES CCn1cc(Nc2nc(Oc3cc(NC(=O)C=C)ccc3F)c3cccn3n2)cn1

InChI Key InChIKey=QDNCZISUJLOWKD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 512307   

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM512307(Preparation of N-(3-((2-((1-ethyl-1H-pyrazol-4-yl)...)
Affinity DataIC50: 0.600nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM512307(Preparation of N-(3-((2-((1-ethyl-1H-pyrazol-4-yl)...)
Affinity DataIC50: 7.70nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
Go to US Patent